1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Leslie's, Inc.
  6. Financials
    LESL   US5270641096

LESLIE'S, INC.

(LESL)
  Report
Delayed Nasdaq  -  04:00 2022-07-05 pm EDT
15.88 USD   +4.96%
07/01Wolfe Research Adjusts Price Target on Leslie's to $17 From $25, Maintains Outperform Rating
MT
07/01Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors
MT
06/27Goldman Sachs Lowers Leslie's Price Target to $19 From $27, Maintains Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: October 2021 2022 2023 2024
Capitalization1 3 9082 903--
Enterprise Value (EV)1 4 3573 3433 2583 082
P/E ratio 30,7x16,4x14,3x12,7x
Yield ----
Capitalization / Revenue 2,91x1,82x1,69x1,58x
EV / Revenue 3,24x2,09x1,90x1,68x
EV / EBITDA 16,1x10,4x9,31x8,12x
Price to Book -18,0x-15,6x-99,3x12,7x
Nbr of stocks (in thousands) 189 778182 839--
Reference price (USD) 20,615,915,915,9
Announcement Date 12/09/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: October 2019 2020 2021 2022 2023 2024
Net sales1 9281 1121 3431 5961 7141 834
EBITDA1 -183271322350380
Operating profit (EBIT)1 -146244288319345
Operating Margin -13,2%18,2%18,1%18,6%18,8%
Pre-Tax Profit (EBT)1 -61,2163243276304
Net income1 0,7058,6127183208228
Net margin 0,08%5,27%9,43%11,5%12,2%12,4%
EPS2 -0,370,670,971,111,25
Dividend per Share2 ------
Announcement Date 10/07/202012/21/202012/09/2021---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: October 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales1 409185228695490202
EBITDA1 82,01,108,702031112,65
Operating profit (EBIT)1 74,6-8,152,12196101-7,13
Operating Margin 18,3%-4,41%0,93%28,2%20,7%-3,54%
Pre-Tax Profit (EBT)1 59,3-19,7-11,118587,6-16,0
Net income1 44,5-14,5-7,4413867,0-12,0
Net margin 10,9%-7,82%-3,26%19,9%13,7%-5,95%
EPS2 0,23-0,08-0,040,750,34-0,06
Dividend per Share ------
Announcement Date 12/09/202102/03/202205/05/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: October 2019 2020 2021 2022 2023 2024
Net Debt1 -1 031449440355179
Net Cash position1 ------
Leverage (Debt / EBITDA) -5,64x1,66x1,36x1,01x0,47x
Free Cash Flow1 -82,8141191202-
ROE (Net Profit / Equities) -----250%
Shareholders' equity1 -----91,3
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 --5,28-1,15-1,02-0,161,25
Cash Flow per Share2 --0,890,781,30-
Capex1 -20,628,934,640,235,0
Capex / Sales -1,85%2,15%2,17%2,35%1,91%
Announcement Date 10/07/202012/21/202012/09/2021---
1 USD in Million
2 USD
Estimates
Key data
Capitalization (USD) 2 903 477 333
Net sales (USD) 1 342 917 000
Number of employees 3 700
Sales / Employee (USD) 362 951
Free-Float 96,1%
Free-Float capitalization (USD) 2 790 002 204
Avg. Exchange 20 sessions (USD) 39 893 425
Average Daily Capital Traded 1,37%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA